231 results
Page 5 of 12
6-K
EX-99.1
3bkdfdm2nn8p
16 Aug 22
SciSparc Signs a Non-Binding Letter of Intent to Acquire American Food Supplements and Cosmetics Brand in Approximately $20 Million Deal
6:30am
6-K
EX-99.1
ofd zu1gm
12 Aug 22
SciSparc Issued Israeli Patent for its Core Technology for Treating Central Nervous Systems Disorders
4:05pm
6-K
EX-99.1
j2dzd ln02pk1d
11 Aug 22
Current Report
4:05pm
6-K
EX-99.1
64slboomy4vf7k2m9
11 Aug 22
SciSparc Announces Israeli Ministry of Health Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
8:42am
6-K
EX-99.1
pei4qmgu
2 Aug 22
SciSparc Signs Clinical Trial Agreement with Yale University to Conduct its Phase IIb Trial in Tourette Syndrome
4:00pm
F-3
3rqsfq5
7 Jul 22
Shelf registration (foreign)
4:22pm
6-K
EX-99.1
rd0gruw0poi8k4yi
7 Jul 22
Report of Foreign Private Issuer
4:00pm
6-K
EX-99.1
f2j 4tuwdftk
7 Jul 22
Report of Foreign Private Issuer
7:49am
6-K
EX-99.1
7klv911
29 Jun 22
SciSparc Successfully Completed The Development of its Proprietary Drug Candidate SCI-110 for its Upcoming Phase IIb Study In Tourette Syndrome
8:36am
6-K
EX-99.1
3gyvct0 h7
24 Jun 22
SciSparc Announces Ethics Committee Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
8:52am
6-K
EX-99.1
kb577r7km2ftz5cx
9 Jun 22
SciSparc’s Board of Directors Provides Strategic Decision
8:38am
6-K
EX-99.1
xtgde46orfu3g
2 Jun 22
Report of Foreign Private Issuer
4:30pm
6-K
EX-99.1
y8s8tyyr51cosqoxyq0o
1 Jun 22
SciSparc to Collaborate with Polyrizon for Brain Targeting Using Intranasal Hydrogel Systems
4:11pm
6-K
EX-99.2
26j43
27 May 22
SciSparc Announces Pricing of $10 Million Private Placement Priced At-the-Market
4:10pm
6-K
EX-99.1
4pthip 2g1ko7iyv
27 May 22
SciSparc Announces Pricing of $10 Million Private Placement Priced At-the-Market
4:10pm
6-K
EX-99.1
z11u2vu8 io
26 May 22
SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial in Tourette Syndrome
8:33am
6-K
EX-99.1
5vyle8d
24 May 22
SciSparc and Clearmind Medicine Inc. Collaboration Yields Positive Results for its Psychedelic Combination Treatment
8:31am
6-K
EX-99.1
n26cy
11 May 22
SciSparc Ltd. and Clearmind Medicine Inc. Collaboration Yields New Patent Application for Psychedelic Combination Treatment for Binge Behaviors
1:58pm
POS AM
jwdcrg3e lrj
28 Apr 22
Prospectus update (post-effective amendment)
5:20pm